CLINICAL_TRIALS
trial_result
· 2017-06-14
Clinical Trial Update: Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI [NA]
Summary
A completed clinical trial evaluating sunitinib therapy in renal cell carcinoma, monitored with F-18 FDG PET/CT and dynamic contrast-enhanced MRI to assess resp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Kidney Neoplasms, Carcinoma, Renal Cell | NA | Status: COMPLETED | Results posted: 2017-06-14